Clinical trial NCT03274544 - References

Idiopathic Pulmonary Fibrosis — Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF)

Citation(s)

•   Antonio GE, Wong KT, Hui DS, Wu A, Lee N, Yuen EH, Leung CB, Rainer TH, Cameron P, Chung SS, Sung JJ, Ahuja AT
  Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology. 2003 Sep;228(3):810-5. Epub 2003 Jun 12.
•   Bensky, D
  , Clavey, S., Stöger, E. 2004. Chinese Herbal Medicine Materia Medica, 3rd Edition. Seattle: Eastland Press, Inc. 1311pp.
•   Chan KS, Zheng JP, Mok YW, Li YM, Liu YN, Chu CM, Ip MS
  SARS: prognosis, outcome and sequelae. Respirology. 2003 Nov;8 Suppl:S36-40. Review.
•   Chen, J
  K., Chen, T.T. 2004. Chinese Medical Herbology and Pharmacology. City of Industry, CA: Art of Medicine Press, Inc. 1267pp.
•   Costabel U, King TE
  International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J. 2001 Feb;17(2):163-7.
•   Erbes R, Schaberg T, Loddenkemper R
  Lung function tests in patients with idiopathic pulmonary fibrosis. Are they helpful for predicting outcome? Chest. 1997 Jan;111(1):51-7.
•   Fruehauf, H
  1997. The Gingko. Cultural Background and Medicinal Usage in China. Journal of Chinese Medicine 55: 13-16.
•   Gribbin J, Hubbard RB, Le Jeune I, Smith CJ, West J, Tata LJ
  Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006 Nov;61(11):980-5. Epub 2006 Jul 14.
•   Han MK, Murray S, Fell CD, Flaherty KR, Toews GB, Myers J, Colby TV, Travis WD, Kazerooni EA, Gross BH, Martinez FJ
  Sex differences in physiological progression of idiopathic pulmonary fibrosis. Eur Respir J. 2008 Jun;31(6):1183-8. doi: 10.1183/09031936.00165207. Epub 2008 Mar 5.
•   Hsu CH, Lu CM, Chang TT
  Efficacy and safety of modified Mai-Men-Dong-Tang for treatment of allergic asthma. Pediatr Allergy Immunol. 2005 Feb;16(1):76-81.
•   Huangdi Neijing (The Book of Yellow Emperor's: a classic of internal medicine) written during the period 475-225 b
  C. as a dialogue between the mythical Emperor Huangdi and his physician Qibo.
•   Jin Gui Yao Lue (Essentials from the Golden Cabinet), written by Zhang Zhong-jing (about 150-219) in Later Han Dynasty
  
•   Jones PW, Quirk FH, Baveystock CM, Littlejohns P
  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992 Jun;145(6):1321-7.
•   Jones PW, Quirk FH, Baveystock CM
  The St George's Respiratory Questionnaire. Respir Med. 1991 Sep;85 Suppl B:25-31; discussion 33-7.
•   Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH
  Association among SF36 quality of life measures and nutrition, hospitalization, and mortality in hemodialysis. J Am Soc Nephrol. 2001 Dec;12(12):2797-806.
•   King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM
  Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med. 2001 Oct 1;164(7):1171-81.
•   Mannino DM, Etzel RA, Parrish RG
  Pulmonary fibrosis deaths in the United States, 1979-1991. An analysis of multiple-cause mortality data. Am J Respir Crit Care Med. 1996 May;153(5):1548-52.
•   Murphy, B
  , Herrman, H., Hawthorne, G., Pinzone, T., Evert, H. 2000. Australian WHOQoL instruments: User's manual and interpretation guide. Australian WHOQoL Field Study Centre, Melbourne, Australia.
•   Navaratnam V, Fleming KM, West J, Smith CJ, Jenkins RG, Fogarty A, Hubbard RB
  The rising incidence of idiopathic pulmonary fibrosis in the U.K. Thorax. 2011 Jun;66(6):462-7. doi: 10.1136/thx.2010.148031. Epub 2011 Apr 27.
•   Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK
  Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med. 2007 Aug 1;176(3):277-84. Epub 2007 May 3.
•   Rafii R, Juarez MM, Albertson TE, Chan AL
  A review of current and novel therapies for idiopathic pulmonary fibrosis. J Thorac Dis. 2013 Feb;5(1):48-73. doi: 10.3978/j.issn.2072-1439.2012.12.07.
•   Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Müller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schünemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis
  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
•   Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G
  Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006 Oct 1;174(7):810-6. Epub 2006 Jun 29.
•   Tang ling Hua, Li Chun sheng
  special onset of diffuse interstitial pulmonary fibrosis treated 13 cases reported. Traditional Chinese Medicine, 1997, 38 (1): 34 ~ 36.
•   World Health Organization 1993
  WHOQoL Study Protocol. WHO (MNH7PSF/93.9).
•   World Health Organization
  2004. WHO Quality of Life-BREF (WHOQOL-BREF). http://www.who.int/substance_abuse/research_tools/whoqolbref/en/, http://www.who.int/substance_abuse/research_tools/en/english_whoqol.pdf Accessed 09 April 2011.
•   Xie L, Liu Y, Fan B, Xiao Y, Tian Q, Chen L, Zhao H, Chen W
  Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge. Respir Res. 2005 Jan 8;6:5.
•   Yang J, Cui Y, Kolb M
  How useful is traditional herbal medicine for pulmonary fibrosis? Respirology. 2009 Nov;14(8):1082-91. doi: 10.1111/j.1440-1843.2009.01644.x. Review.
•   Yao CF, Jiang SL
  [Prevention and treatment of pulmonary-fibrosis by traditional Chinese medicine]. Zhong Xi Yi Jie He Xue Bao. 2003 Sep;1(3):234-8. Review. Chinese.
•   Zhang
  L. 1999. A Case Report on Chronic Lymphocytic Leukemia. Journal of Traditional Chinese Medicine Alumni 1: 15.
•   Zhou L, Zuo Z, Chow MS
  Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol. 2005 Dec;45(12):1345-59. Review.

The Effectiveness of an Empirical Chinese Medicine Formulation for Idiopathic Pulmonary Fibrosis: an Open Label Clinical Trial

Details for clinical trial NCT03274544